The FDA has approved Insmed’s Brinsupri™ (brensocatib 10 mg and 25 mg tablets) as the first drug authorized to treat ...

Researchers say COMET’s architecture may also support other areas of nanotechnology where multi-component formulations are critical.

A new approach triggers meiosis, the cell division process responsible for producing egg and sperm, to aid future fertility treatments.

Dementia-like protein clumps found in pancreatic precancer mouse cells point to autophagy defects, offering cancer ...

PepMLM generates binders to challenging therapeutic targets across cancer and neurological disease using protein sequence and ...

Made Scientific's new facility opening marks the completion of a $12 million initial investment in facility upgrades and equipment.

Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

Model serves as platform for understanding how chronic inflammation related to alcohol consumption accelerates pancreatic cancer development.

Researchers demonstrate that an engineered antibody improves a class of drugs that has struggled to make good on its early promise.

Peptidoglycan hydrolases killed living bacteria, opening the door for further research into the interplay between archaea and bacteria.

The two designed compounds, dubbed NG1 and DN1, effectively treated N. gonorrhoeae and S. aureus respectively in preclinical models.